abstract |
The present invention relates to the use of vasopressin V1a receptor antagonists for the treatment of male dysfunction, especially ejaculation disorders such as premature ejaculation or premature ejaculation. The invention also relates to a method for treating male dysfunction, especially ejaculation disorders such as premature ejaculation or early ejaculation. The present invention also relates to a test method for screening compounds useful for the treatment of male dysfunction, particularly ejaculation disorders such as premature ejaculation or early ejaculation, by screening for compounds that are V1a receptor antagonists. |